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How many of your patients were on calcium channel 
blockers, and did this seem to ameliorate the changes that 
you have reported? 
Dr. Erdoes. That's a good question. The process in the 
coronary arteries appears to be different than in the" 
peripheral vessels. We studied the pathology of all plaques 
removed from our operated patients, and they were the 
garden-variety atherosclerotic plaque, as opposed to those 
in the coronary circulation where you have a concentric 
luminal narrowing, and it is believed to be an immune 
phenomenon. 
It is not certain if calcium channel blockers work by 
decreasing the blood pressure or by some other calcium- 
dependent mechanism or whether due to their immune 
suppressive effect. Most of our patients were treated with 
either angiotensin-converting e zyme inhibitors or calcium 
channel blockers, and we did not study the specifics of 
which patients received which antihypertensive drug. 
L IFEL INE  FOUNDATION RESEARCH AWARD 
The Lifeline Foundation of the Society for Vascular Surgery and the International 
Society for Cardiovascular Surgery, North American Chapter, invites grant applications 
for funding of meritorious research by young surgical investigators. The awards are in- 
tended for surgeons who have completed their formal surgical education in general sur- 
gery and who have completed or are in an advanced training program in vascular surgery. 
To be considered for selection acandidate: 
1. Should be certified by the American Board of Surgery or have completed the 
requirements for certification 
2. Should submit an application within 5 years of completion of an approved vas- 
cular surgery residency training program 
3. Must have either a faculty appointment in an approved medical school in the 
United States or Canada or have received an academic appointment within the 
guidelines of the applicant's institution 
Grant awards are not intended to supplement salary, which will remain the responsi- 
bility of the institution in which the awardee holds an appointment. The awardee is 
expected to devote a significant amount of time to the funded project. A progress report 
must be presented to the Executive Committee of the Foundation by the following April 
1, and, on completion of the project, a brief oral report is to be presented to the 
memberships of the two societies during a plenary session at the Joint Annual Meeting. 
A grant awards committee will review competitive applications. It is anticipated that 
two grants will be awarded annually totaling $50,000 each to include indirect costs. The 
$50,000 grant includes funding to enable the awardee to attend the Joint Annual Meeting 
of the Vascular Societies to receive his or her award in the year of selection. Each award 
will be for 1 year with the option to extend for an additional year. 
Holders of substantial research awards, such as an NIH ROI, FIRST Award, or 
similar support, are ineligible. The applicant must append to the application the abstracts 
of any funded or pending rants. 
Grant applications may be obtained from: 
Chairman 
Research and Education Committee 
The Lifeline Foundation 
Thirteen Elm St. 
Manchester, MA 01944 
(508)526-8330 
The deadline for receiving applications in the Foundation office is January 15, 
1996. Funds will be awarded by July 1, 1996. 
